235 related articles for article (PubMed ID: 12475456)
1. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ
J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.
Jeremias A; Albirini A; Ziada KM; Chew DP; Brener SJ; Topol EJ; Ellis SG
Am Heart J; 2002 Jun; 143(6):1040-5. PubMed ID: 12075261
[TBL] [Abstract][Full Text] [Related]
3. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
[TBL] [Abstract][Full Text] [Related]
4. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
[TBL] [Abstract][Full Text] [Related]
5. Troponin I elevation and cardiac events after percutaneous coronary intervention.
Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
[TBL] [Abstract][Full Text] [Related]
6. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS).
Costa MA; Carere RG; Lichtenstein SV; Foley DP; de Valk V; Lindenboom W; Roose PC; van Geldorp TR; Macaya C; Castanon JL; Fernandez-Avilèz F; Gonzáles JH; Heyer G; Unger F; Serruys PW
Circulation; 2001 Nov; 104(22):2689-93. PubMed ID: 11723020
[TBL] [Abstract][Full Text] [Related]
7. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
[TBL] [Abstract][Full Text] [Related]
8. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery.
Domanski MJ; Mahaffey K; Hasselblad V; Brener SJ; Smith PK; Hillis G; Engoren M; Alexander JH; Levy JH; Chaitman BR; Broderick S; Mack MJ; Pieper KS; Farkouh ME
JAMA; 2011 Feb; 305(6):585-91. PubMed ID: 21304084
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions.
Kornowski R; Fuchs S; Hong MK; Mehran R; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
Catheter Cardiovasc Interv; 2000 Oct; 51(2):131-7. PubMed ID: 11025563
[TBL] [Abstract][Full Text] [Related]
10. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy.
Ellis SG; Chew D; Chan A; Whitlow PL; Schneider JP; Topol EJ
Circulation; 2002 Sep; 106(10):1205-10. PubMed ID: 12208794
[TBL] [Abstract][Full Text] [Related]
11. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
[TBL] [Abstract][Full Text] [Related]
12. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
Nageh T; Sherwood RA; Harris BM; Byrne JA; Thomas MR
Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
[TBL] [Abstract][Full Text] [Related]
13. Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality.
Marso SP; Bliven BD; House JA; Muehlebach GF; Borkon AM
Eur Heart J; 2003 Jul; 24(14):1323-8. PubMed ID: 12871689
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
Saucedo JF; Mehran R; Dangas G; Hong MK; Lansky A; Kent KM; Satler LF; Pichard AD; Stone GW; Leon MB
J Am Coll Cardiol; 2000 Apr; 35(5):1134-41. PubMed ID: 10758952
[TBL] [Abstract][Full Text] [Related]
15. Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.
Gregson J; Stone GW; Ben-Yehuda O; Redfors B; Kandzari DE; Morice MC; Leon MB; Kosmidou I; Lembo NJ; Brown WM; Karmpaliotis D; Banning AP; Pomar J; Sabaté M; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Pocock SJ
J Am Coll Cardiol; 2020 Oct; 76(14):1609-1621. PubMed ID: 33004126
[TBL] [Abstract][Full Text] [Related]
16. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
Roe MT; Mahaffey KW; Kilaru R; Alexander JH; Akkerhuis KM; Simoons ML; Harrington RA; Tardiff BE; Granger CB; Ohman EM; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Topol EJ
Eur Heart J; 2004 Feb; 25(4):313-21. PubMed ID: 14984920
[TBL] [Abstract][Full Text] [Related]
17. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?
Akkerhuis KM; Alexander JH; Tardiff BE; Boersma E; Harrington RA; Lincoff AM; Simoons ML
Circulation; 2002 Feb; 105(5):554-6. PubMed ID: 11827918
[TBL] [Abstract][Full Text] [Related]
18. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
[TBL] [Abstract][Full Text] [Related]
20. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
Registro Osservazionale Angina Instabile Investigators
Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
